|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
4
|
Resverlogix Corp.
|
Dec 18, 2017 10:09AM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
4
|
Resverlogix Corp.
|
Dec 18, 2017 10:55AM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
2
|
Resverlogix Corp.
|
Dec 18, 2017 01:11PM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
3
|
Resverlogix Corp.
|
Dec 18, 2017 04:16PM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
6
|
Resverlogix Corp.
|
Sep 19, 2018 02:23AM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
3
|
Resverlogix Corp.
|
Sep 19, 2018 12:07PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
8
|
Resverlogix Corp.
|
Mar 20, 2022 12:38AM
|
|
Re: RVX Current Status
|
5
|
Resverlogix Corp.
|
Feb 27, 2020 04:26PM
|
|
Re: RVX gets Breakthrough Therapy Designation!!!
|
4
|
Resverlogix Corp.
|
Feb 03, 2020 10:57AM
|
|
Re: RVX Long Covid Trial
|
2
|
Resverlogix Corp.
|
May 29, 2023 02:42AM
|
|
Re: RVX Market Price
|
3
|
Resverlogix Corp.
|
Mar 10, 2017 01:28PM
|
|
Re: RVX on local Calgary CTV at 5 and 6pm on 11 March
|
5
|
Resverlogix Corp.
|
Mar 12, 2021 07:52PM
|
|
Re: RVX-208 and Rosuvastatin Patent
|
2
|
Resverlogix Corp.
|
Dec 13, 2016 01:54PM
|
|
Re: RVX-208 Commercialization and Stock Liquidity? .......
|
4
|
Resverlogix Corp.
|
Mar 02, 2019 03:07PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 03:27PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 04:19PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
5
|
Resverlogix Corp.
|
Jan 08, 2019 12:32PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
4
|
Resverlogix Corp.
|
Jan 09, 2019 02:17PM
|
|
Re: RVX-Zenith
|
6
|
Resverlogix Corp.
|
Jan 29, 2017 07:02PM
|
|
Re: RVX.WT
|
1
|
Resverlogix Corp.
|
Jan 08, 2021 03:30PM
|
